PRIONEX THE BSA ALTERNATIVE

Serial Number 88620661
Registration 6212351
700

Registration Progress

Application Filed
Sep 17, 2019
Under Examination
Apr 21, 2020
Approved for Publication
Feb 25, 2020
Published for Opposition
Feb 25, 2020
Registered
Dec 1, 2020

Trademark Image

PRIONEX THE BSA ALTERNATIVE

Basic Information

Serial Number
88620661
Registration Number
6212351
Filing Date
September 17, 2019
Registration Date
December 1, 2020
Published for Opposition
February 25, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 1, 2020
Registration
Registered
Classes
001 005

Rights Holder

PENTAPHARM AG

25
Address
DORNACHERSTRASSE 112
AESCH BL 4147
CH

Ownership History

DSM IP Assets B.V.

Original Applicant
99
HEERLEN NL

DSM IP Assets B.V.

Owner at Publication
99
HEERLEN NL

DSM IP Assets B.V.

Original Registrant
99
HEERLEN NL

PENTAPHARM AG

New Owner After Registration #1
25
AESCH BL CH

Legal Representation

Attorney
Duane M. Byers

USPTO Deadlines

Next Deadline
496 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-12-01)
Due Date
December 01, 2026
Grace Period Ends
June 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Feb 1, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 1, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 27, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 27, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 26, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 24, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 24, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 23, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 14, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 14, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 14, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 14, 2020 IUAF S USE AMENDMENT FILED Loading...
Apr 21, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 25, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 25, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 5, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 22, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 21, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 20, 2020 ALIE A ASSIGNED TO LIE Loading...
Jan 7, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 17, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 17, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 17, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 17, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 24, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 20, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Diagnostic preparations for scientific or research use; Chemical additives for use in the manufacture of pharmaceuticals
First Use Anywhere: 20190800
First Use in Commerce: 20190800
Class 005
Diagnostic preparations for medical purposes; Pharmaceutical preparations, namely, polypeptide fractions of porcine collagen for use in protein stabilization and for use in tissue culture and cell culture
First Use Anywhere: 20190800
First Use in Commerce: 20190800

Classification

International Classes
001 005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THE BSA ALTERNATIVE"